236 related articles for article (PubMed ID: 1698639)
1. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses.
Matsubayashi Y; Hirama T; Morioka A; Iwashiro M; Masuda T; Uchino H; Takeshita S; Yamagishi H; Udono H; Mieno M
Eur J Immunol; 1990 Sep; 20(9):2095-103. PubMed ID: 1698639
[TBL] [Abstract][Full Text] [Related]
2. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
[TBL] [Abstract][Full Text] [Related]
4. Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution.
Hirama T; Takeshita S; Matsubayashi Y; Iwashiro M; Masuda T; Kuribayashi K; Yoshida Y; Yamagishi H
Eur J Immunol; 1991 Feb; 21(2):483-8. PubMed ID: 1705514
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
[TBL] [Abstract][Full Text] [Related]
6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
7. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
Kuhröber A; Schirmbeck R; Reimann J
Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
[TBL] [Abstract][Full Text] [Related]
9. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
10. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
Havran WL; Fitch FW
J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
[TBL] [Abstract][Full Text] [Related]
11. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
13. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
15. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
16. Two ultraviolet tumor-specific suppressor cell clones. One expresses Ig RNA and the other expresses T cell receptor-alpha and -beta RNA.
Kraig E; Kannapell CC; Fischbach K; Zellmer V; Trial J
J Immunol; 1990 Oct; 145(7):2050-6. PubMed ID: 2168916
[TBL] [Abstract][Full Text] [Related]
17. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
Kuhröber A; Schirmbeck R; Reimann J
Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
[TBL] [Abstract][Full Text] [Related]
18. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
19. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
20. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
Lancki DW; Kaper BP; Fitch FW
J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]